Nonetheless, the initial expression of VEGF-a can beconsidered neuroprotective as it promotes neuronal survival and encourages theproduction of interleukin-6 (IL-6) in ECs, which has demonstrated to beprotective of MG under hyperglycemic conditions. The gene discussed is IL6; the disease is myasthenia gravis.